128 related articles for article (PubMed ID: 6500507)
1. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.
Ponzetto A; Seeff LB; Buskell-Bales Z; Ishak KG; Hoofnagle JH; Zimmerman HJ; Purcell RH; Gerin JL
Hepatology; 1984; 4(6):1111-5. PubMed ID: 6500507
[TBL] [Abstract][Full Text] [Related]
2. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.
Raimondo G; Smedile A; Gallo L; Balbo A; Ponzetto A; Rizzetto M
Lancet; 1982 Jan; 1(8266):249-51. PubMed ID: 6120275
[TBL] [Abstract][Full Text] [Related]
3. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
[TBL] [Abstract][Full Text] [Related]
4. Chronic delta hepatitis: a difficult problem for the hepatologist.
Picciotto A; Celle G
Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and D virus infection among drug abusers in Taiwan.
Lee SD; Wang JY; Wu JC; Chiang YT; Tsai YT; Lo KJ
J Med Virol; 1986 Nov; 20(3):247-52. PubMed ID: 3783132
[TBL] [Abstract][Full Text] [Related]
7. Delta infection among patients with chronic hepatitis B in the Stockholm region.
Lindh G; Weiland O; Hansson BG; Svedmyr A
Infection; 1984; 12(1):27-30. PubMed ID: 6706409
[TBL] [Abstract][Full Text] [Related]
8. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers.
Hadziyannis SJ; Sherman M; Lieberman HM; Shafritz DA
Hepatology; 1985; 5(4):544-7. PubMed ID: 4018727
[TBL] [Abstract][Full Text] [Related]
9. Infection with delta agent in Sweden: introduction of a new hepatitis agent.
Hansson BG; Moestrup T; Widell A; Nordenfelt E
J Infect Dis; 1982 Oct; 146(4):472-8. PubMed ID: 7119477
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic usefulness of anti-HBc-IgM and anti-HD antibodies in acute viral hepatitis.
Esteban R; Buti M; Jardi R; Hernandez JM; Bacardi R
Gastroenterol Clin Biol; 1986 Nov; 10(11):748-51. PubMed ID: 3803810
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan.
Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS
J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445
[TBL] [Abstract][Full Text] [Related]
12. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects of delta infection.
Moestrup T; Hansson BG; Widell A; Nordenfelt E
Br Med J (Clin Res Ed); 1983 Jan; 286(6359):87-90. PubMed ID: 6401506
[TBL] [Abstract][Full Text] [Related]
14. Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.
Shattock AG; Irwin FM; Morgan BM; Hillary IB; Kelly MG; Fielding JF; Kelly DA; Weir DG
Br Med J (Clin Res Ed); 1985 May; 290(6479):1377-80. PubMed ID: 3922501
[TBL] [Abstract][Full Text] [Related]
15. The delta agent in acute and chronic hepatitis B infection in Sweden.
Norkrans G; Hermodsson S; Iwarson S
Scand J Gastroenterol; 1983 Jul; 18(5):675-8. PubMed ID: 6675189
[TBL] [Abstract][Full Text] [Related]
16. Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication.
Chen PJ; Chen DS; Chen CR; Chen YY; Chen HM; Lai MY; Sung JL
Hepatology; 1988; 8(5):1121-4. PubMed ID: 3417233
[TBL] [Abstract][Full Text] [Related]
17. Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins.
Ponzetto A; Hoofnagle JH; Seeff LB
Gastroenterology; 1984 Dec; 87(6):1213-6. PubMed ID: 6092192
[TBL] [Abstract][Full Text] [Related]
18. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
[TBL] [Abstract][Full Text] [Related]
19. Infection with the delta agent in chronic HBsAg carriers.
Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
[TBL] [Abstract][Full Text] [Related]
20. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]